Diarrhea Clinical Trial
Official title:
Evaluation to Assess the Asili Intervention in South Kivu, Democratic Republic of Congo
The South Kivu province of DRC has experience continuous armed conflict over the last several decades; as a result, livelihoods and health metrics are uniformly poor. Thus, the objective of this study is to determine if an integrated set of social enterprises can improve child health while offering viable and scalable new business opportunities for the community. Specific research questions include the impact of the individual enterprises on (1) child health, (2) access to clean water, and (3) economic opportunities in the region.
The South Kivu province of DRC has experience continuous armed conflict over the last several
decades; as a result, livelihoods and health metrics are uniformly poor. Thus, the objective
of this study is to determine if an integrated set of social enterprises can improve child
health while offering viable and scalable new business opportunities for the community.
Asili ("foundation" in Swahili) is an innovative initiative that aims to implement a suite of
social enterprises to provide basic services and employment opportunities in South Kivu, DRC.
Asili was co-created by the American Refugee Committee (ARC), an independent non-profit, and
IDEO.org using a methodology known as human-centered design (HCD); based on the process, a
model of multiple businesses to meet multiple needs was developed, linked under the Asili
membership system and coordinated through a centralized database. The Asili model is unique
in bringing self-sustaining social enterprises together on a common operational platform to
improve both health and economic opportunity in the region. These enterprises are 1) clean
water and 2) high quality healthcare clinics.
The team at Stanford University has been recruited as the external evaluator to conduct an
impact evaluation of Asili in order to determine whether or not the project goals of reduced
child disease as well as increased economic capacity are met. The primary outcome of this
impact evaluation study is to determine the effect of the Asili intervention on improving the
health of children under five from baseline. Secondary outcomes of this study are to
determine the impact of the intervention on enhanced economic activity, food security, and
maternal self-esteem and self-efficacy. The investigators hypothesize that under-five
children in Asili households will have lower incidence of diarrhea, fever, and cough/short,
rapid breathing as well as a higher incidence of vaccination rates.
There is little research on the effects of social enterprise/HCD interventions on health,
child health in particular, especially in areas recovering from recent conflict. Therefore,
the investigators' aim is to determine if a multi-sectoral approach that can improve
livelihoods in DRC can also improve family and child health.
This study will use household surveys at two time points (baseline and endline) to collect
information on key indicators from the target populations. For Zones 3 and 4, encouragement
design will be used to provide an instrumental variable to analyze the difference in outcomes
between the households that enroll in Asili and those that do not. Specific research
questions include the impact of the individual enterprises on (1) child health, (2) access to
clean water, and (3) economic opportunities in the region.
Encouragement design, a variation on the more commonly known randomized control trial (RCT),
is a useful alternative for interventions where it is impractical to require adherence by
participants or in situations where offering the intervention to a portion of the population
is not possible or ethical. Encouragement involves randomly assigning participants to the
"opportunity" or encouragement arm, where efforts are made to motivate participants to take
part in an intervention or receive a particular treatment, but are allowed to choose whether
or not they actually participate.
Because Asili services will be offered and available to all members of the community and
controlling access to services is not possible, encouragement design will be utilized to
measure uptake of Asili. Families will be randomly sampled based on location, and a team of 2
local community champions/data collectors (hired from within the community) will visit each
of the encouragement arm homes, supervised by a community outreach liaison. Community
champions will be responsible for visiting each home, going door-to-door and speaking with
each family individually in order to avoid contamination/cross-over with control households.
Champions will spend between 25-45 minutes with members of each household, during which they
will explain how Asili works, what the intervention encompasses, and the benefits of joining
Asili. The investigators hope to foster a sense of trust in the participants randomized to
the encouragement arm by engaging data collectors from the community for these one-on-one
exchanges with each household. Control households will also have equal access to Asili
services; however, those households will not be visited by community champions individually.
The study populations in the two Zones include families surveyed from the catchment area of
the Asili project intervention site in South Kivu. Each of these zones has a population of
approximately 10,000 individuals; approximately 850 households were recruited at baseline in
each of Zones 3 and 4. Baseline data was completed in Zones 3 and 4 in August 2016 and July
2017, respectively, and follow-up is anticipated in April/May 2018.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06283784 -
Study To Evaluate The Efficacy of a Proprietary Mix of Live Probiotics In The Prophylaxis Of Diarrhea In Adult Patients
|
N/A | |
Recruiting |
NCT03851835 -
Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis
|
Phase 3 | |
Completed |
NCT04003181 -
The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon
|
N/A | |
Completed |
NCT03596827 -
The Protective Immune Response to Attenuated Enterotoxigenic Escherichia Coli Infection
|
N/A | |
Recruiting |
NCT05372068 -
Cement flooRs AnD chiLd hEalth (CRADLE)
|
N/A | |
Completed |
NCT03972618 -
Evaluation of the Efficacy of Sawyer Point One Filters in Schools and Homes in the Dominican Republic
|
N/A | |
Completed |
NCT05207618 -
Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant
|
N/A | |
Not yet recruiting |
NCT05052489 -
Registry and Clinical Observation of Children With Diarrhoeal Disease
|
||
Completed |
NCT02428647 -
Lao Zinc Study: Effects of Two Forms of Daily Preventive Zinc Versus Therapeutic Zinc Supplementation
|
N/A | |
Completed |
NCT02541695 -
Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli
|
N/A | |
Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
Completed |
NCT01968408 -
Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children
|
Phase 3 | |
Completed |
NCT01739231 -
Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults
|
Phase 1/Phase 2 | |
Completed |
NCT01438645 -
ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy
|
N/A | |
Not yet recruiting |
NCT01382199 -
Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients
|
Phase 3 | |
Terminated |
NCT01472211 -
Water-based Zinc Intervention Trial in Zinc Deficient Children
|
Phase 0 | |
Terminated |
NCT01048567 -
Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly
|
Phase 2 | |
Completed |
NCT01371656 -
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
|
Phase 3 | |
Completed |
NCT00914225 -
Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya
|
N/A | |
Completed |
NCT00760851 -
Yogurt Study in Children 2-4 Years Old Attending Daycare
|
Phase 3 |